Emerald Advisers’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-642,226
Closed -$2.65M 363
2020
Q3
$2.65M Sell
642,226
-26,816
-4% -$110K 0.11% 122
2020
Q2
$1.71M Buy
669,042
+37,595
+6% +$96.3K 0.07% 128
2020
Q1
$1.83M Buy
631,447
+2,323
+0.4% +$6.71K 0.11% 117
2019
Q4
$2.38M Sell
629,124
-9,970
-2% -$37.8K 0.1% 121
2019
Q3
$3.27M Sell
639,094
-61,082
-9% -$312K 0.15% 114
2019
Q2
$4.34M Buy
700,176
+73,929
+12% +$458K 0.17% 113
2019
Q1
$4.45M Sell
626,247
-24,102
-4% -$171K 0.18% 116
2018
Q4
$5.55M Sell
650,349
-12,195
-2% -$104K 0.27% 105
2018
Q3
$13.3M Buy
662,544
+22,610
+4% +$453K 0.49% 93
2018
Q2
$16.5M Buy
639,934
+13,821
+2% +$357K 0.62% 78
2018
Q1
$15M Buy
626,113
+83,216
+15% +$1.99M 0.6% 71
2017
Q4
$18.4M Buy
542,897
+14,830
+3% +$503K 0.71% 56
2017
Q3
$11.2M Sell
528,067
-4,660
-0.9% -$98.7K 0.45% 87
2017
Q2
$9.32M Buy
532,727
+14,042
+3% +$246K 0.39% 96
2017
Q1
$9.08M Buy
518,685
+140
+0% +$2.45K 0.37% 99
2016
Q4
$8.76M Buy
518,545
+14,071
+3% +$238K 0.37% 98
2016
Q3
$8.28M Sell
504,474
-5,720
-1% -$93.9K 0.37% 101
2016
Q2
$7.72M Hold
510,194
0.37% 97
2016
Q1
$7.38M Buy
510,194
+48,143
+10% +$696K 0.36% 97
2015
Q4
$13.1M Buy
462,051
+110,530
+31% +$3.13M 0.62% 60
2015
Q3
$5.88M Buy
351,521
+2,800
+0.8% +$46.9K 0.31% 111
2015
Q2
$9.14M Buy
348,721
+26,090
+8% +$684K 0.44% 77
2015
Q1
$5.65M Buy
322,631
+82,464
+34% +$1.44M 0.28% 118
2014
Q4
$4.17M Buy
240,167
+79,704
+50% +$1.38M 0.22% 135
2014
Q3
$2.99M Buy
160,463
+8,844
+6% +$165K 0.18% 164
2014
Q2
$2.77M Buy
+151,619
New +$2.77M 0.16% 174